- Release Date: 11/03/24 08:55
- Summary: New case of SCENESSE efficacy in vitiligo presented at AAD
- Price Sensitive: Yes
- Download Document 362.39KB
- Forums
- ASX - By Stock
- CUV
- Ann: New case of SCENESSE efficacy in vitiligo presented at AAD
Ann: New case of SCENESSE efficacy in vitiligo presented at AAD
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.73 |
Change
0.110(0.70%) |
Mkt cap ! $789.1M |
Open | High | Low | Value | Volume |
$15.68 | $15.98 | $15.61 | $1.122M | 71.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 90 | $15.73 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.76 | 99 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 457 | 15.760 |
3 | 191 | 15.750 |
3 | 196 | 15.740 |
6 | 254 | 15.730 |
6 | 833 | 15.720 |
Price($) | Vol. | No. |
---|---|---|
15.790 | 267 | 17 |
15.800 | 3902 | 2 |
15.810 | 118 | 2 |
15.820 | 203 | 4 |
15.830 | 965 | 4 |
Last trade - 14.35pm 28/05/2024 (20 minute delay) ? |
|
|||||
Last
$15.69 |
  |
Change
0.110 ( 0.30 %) |
|||
Open | High | Low | Volume | ||
$15.68 | $15.97 | $15.61 | 3897 | ||
Last updated 14.51pm 28/05/2024 ? |
Featured News
CUV (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online